Search Results - O. N. Miller

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    ATRIAL FIBRILLATION: PRE-HOSPITAL, HOSPITAL, AND AMBULATORY MANAGEMENT TACTICS

    ATRIAL FIBRILLATION: PRE-HOSPITAL, HOSPITAL, AND AMBULATORY MANAGEMENT TACTICS by O. N. Miller, F. I. Belyalov

    Published 2009-08-01

    .

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    IC Class medications in patients with atrial fibrillation, arterial hypertension, chronic heart failure and intact systolic function

    IC Class medications in patients with atrial fibrillation, arterial hypertension, chronic heart failure and intact systolic function by O. N. Miller, O. N. Skurikhina, S. A. Starichkov

    Published 2008-08-01

    The study assessed clinical effectiveness and safety of propanorm in patients with arterial hypertension, chronic heart failure (CHF) without left ventricular systolic dysfunction, complicated with recurrent paroxysmal or persistent atrial fibrillation (AF). It was demonstrated that propanorm was ef...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    CAUSES OF SYNCOPAL CONDITIONS IN YOUNG SUBJECTS

    CAUSES OF SYNCOPAL CONDITIONS IN YOUNG SUBJECTS by O. N. Miller, Z. G. Bondareva, I. A. Guseva

    Published 2003-06-01

    112 patients were studied to evaluate the incidence of syncopal conditions caused by impaired cardiovascular regulation in young subjects. Complex evaluation has found hyperventilation syndrome to be the reason for syncopal conditions in 8.9 %, vasopressor syncopal conditions in 13.4 %, reflex in 16...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    ACE inhibitors and myocardial remodeling in patients with arterial hypertension and atrial fibrillation

    ACE inhibitors and myocardial remodeling in patients with arterial hypertension and atrial fibrillation by O. N. Miller, O. N. Skurikhina, T. A. Gusyatnikova, G. E. Subrakov

    Published 2007-10-01

    The study is focused on assessing dynamics of left atrium volume and volume index after treatment of paroxysmal or persistent atrial fibrillation (AF), during ACE therapy with lipophilic (n=34) or hydrophilic (n=38) «standard» antihypertensive medications. After sinus rhythm restoration, mechanical...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Prevention of atrial fibrillation episodes in patients with chronic heart failure: a new approach to the old problem

    Prevention of atrial fibrillation episodes in patients with chronic heart failure: a new approach to the old problem by Yu. M. Pozdnyakov, O. N. Miller, S. A. Luchinsky, V. L. Doshchitsyn

    Published 1970-01-01

    Aim. To study clinical effectiveness and safety of propafenone and amiodarone in patients with arterial hypertension (AH), coronary heart disease (CHD), chronic heart failure (CHF) with preserved left ventricular (LV) systolic function, and atrial fibrillation (AF). Material and methods. The study i...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    ANTIARRHYTHMIC THERAPY EFFECTIVENESS AND IMPACT ON LEFT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION

    ANTIARRHYTHMIC THERAPY EFFECTIVENESS AND IMPACT ON LEFT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION by O. N. Miller, A. V. Tarasov, Yu. M. Pozdnyakov, S. A. Luchinskyi, V. L. Doshchitsyn

    Published 2011-08-01

    Clinical effectiveness, safety, and the impact on left ventricular (LV) systolic and diastolic function were assessed for Propanorm® and Cordarone® in patients with atrial fibrillation (AF), arterial hypertension (AH), coronary heart disease (CHD), and chronic heart failure (CHF) with preserved ejec...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation

    Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation by A. V. Tarasov, O. N. Miller, Yu. M. Pozdnyakov, S. A. Luchinskyi, V. L. Doshchitsyn

    Published 1970-01-01

    Aim. To study clinical effectiveness, safety, and effects on left ventricular (LV) systolic and diastolic function for Class IC and Class III antiarrhythmic medications — propafenone and amiodarone, respectively — in patients with chronic heart failure (CHF), intact ejection fraction (EF), and atria...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HEART FAILURE WITH INTACT LEFT VENTRICULAR SYSTOLIC FUNCTION

    EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HE... by O. N. Miller, S. A. Starichkov, Yu. M. Pozdnyakov, S. A. Luchinsky, A. V. Tarasov, V. L. Doshchitsyn, O. A. Kramynina, E. G. Volkova, D. L. Ilyinykh

    Published 2010-08-01

    Clinical effectiveness and safety of Propanorm® was studied in patients with arterial hypertension (AH), coronary heart disease (CHD), chronic heart failure (CHF) with intact systolic left ventricular (LV) function, and atrial fibrillation (AF). Effectiveness and safety of Propanorm® was compared to...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    ARTERIAL HYPERTENSION WORKGROUP RESOLUTION. THE ROLE OF SARTANS IN TREATMENT OF SYSTEMIC HYPERTENSION IN THE 21ST CENTURY

    ARTERIAL HYPERTENSION WORKGROUP RESOLUTION. THE ROLE OF SARTANS IN TREATMENT OF SYSTEMIC HYPERTENSION IN THE 21ST CENTURY by A. O. Konradi, O. N. Zhdanova, O. P. Rotar, Yu. A. Karpov, V. I. Podzolkov, P. A. Lebedev, A. I. Chesnikova, D. V. Nebieridze, O. N. Miller, E. V. Solovjova, A. N. Kulikov

    Published 2018-04-01

    .

    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Resolution of the International meeting of experts on the exchange of scientific experience in the use of anticoagulants in patients with COVID-19

    Resolution of the International meeting of experts on the exchange of scientific experience in the use of anticoagulants in patients with COVID-19 by S. N. Avdeev, A. V. Bazarova, E. I. Baranova, A. M. Esayan, G. K. Zhusupova, M. N. Zamyatin, I. V. Zotova, S. L. Kasenova, S. T. Matskeplishvili, O. N. Miller, A. M. Pak, V. V. Salukhov, V. V. Tyrenko, D. R. Khasanova, N. A. Shamalov, S. N. Yanishevsky

    Published 2020-09-01

    С целью получения экспертного мнения по вопросам, связанным с актуальностью, протоколами и режимами антитромботической терапии у пациентов с COVID-19 на госпитальном и амбулаторном этапах лечения 25 июля 2020г была проведена Международная он-лайн встреча экспертов по научному обмену опытом.Группа эк...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    COMORBIDITIES IN PRACTICE. CLINICAL GUIDELINES

    COMORBIDITIES IN PRACTICE. CLINICAL GUIDELINES by R. G. Oganov, I. N. Denisov, V. I. Simanenkov, I. G. Bakulin, N. V. Bakulina, S. A. Boldueva, O. N Barbarash, N. P Garganeeva, V. L Doshchitsin, O. M. Drapkina, E. N. Dudinskaya, Yu. V. Kotovskaya, A. M. Lila, M. N. Mamedov, B. U. Mardanov, O. N. Miller, M. M. Petrova, Yu. M. Pozdnyakov, N. K. Runikhina, S. A. Sayganov, A. V. Tarasov, O. N. Tkacheva, A. M. Urinsky, S. A. Shalnova

    Published 2017-12-01

    .

    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    2020 Clinical practice guidelines for Supraventricular tachycardia in adults

    2020 Clinical practice guidelines for Supraventricular tachycardia in adults by L. A. Bokeria, E. Z. Golukhova, S. V. Popov, E. A. Artyukhina, V. A. Bazaev, R. E. Batalov, O. L. Bokeria, A. B. Vygovsky, M. Yu. Gilyarov, S. P. Golitsyn, K. V. Davtyan, S. A. Zenin, E. A. Ivanitsky, S. G. Kanorsky, A. S. Kovalev, S. N. Krivolapov, D. S. Lebedev, S. E. Mamchur, M. M. Medvedev, O. N. Miller, E. N. Mikhailov, N. M. Neminushchiy, N. A. Novikova, A. Sh. Revishvili, F. G. Rzaev, A. B. Romanov, S. Yu. Serguladze, O. V. Sopov, B. A. Tatarsky, S. A. Thermosesov, A. G. Filatov, M. A. Shkolnikova, Yu. V. Shubik, S. M. Yashin

    Published 2021-06-01

    With the participation: All-Russian Scientific Society of Specialists in Clinical Electrophysiology, Arrhythmology and Pacing, Russian Association of Cardiovascular SurgeonsEndorsed by: Research and Practical Council of the Ministry of Health of the Russian Federation

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: